四川医学2011，Vol.32Issue(3)：347-348,2.
血清β2-微球蛋白和C-反应蛋白水平检测在多发性骨髓瘤患者诊断、疗效监测和预后判断中的临床意义
Clinical value of determination of β2-MG and CRP levels in patients with multiple myeloma.
况小红 1童浩 1贾霖1
作者信息
- 1. 绵阳市第三人民医院血液肿瘤科,四川,绵阳,621000
- 折叠
摘要
Abstract
Objective To study the clinical significance of determination of plasma levels ofβ2-MG and CRP in patients with multiple myeloma (MM).Methods Plasma levels of TNF-α and β2-m were determined in 42 patients with multiple myeloma before and after chemotherapy, and it also been determined in 50 healthy controls.Results The plasma levels of β2-MG and CRP in patients with multiple myeloma were significantly higher than those controls (P ＜ 0.01 ).The plasma levels of β2-MG and CRP were decreases after the chemotherapy.And there had a long surval time in patients with a lower plasma levels of β2-MG and CRP than those with a higher level.Conclusion The determination of plasma levels ofβ2-MG and ClP might be helpful for diagnosis , curative effect monitoring and prognosis in patients with multiple myeloma.关键词
β2微球蛋白/C反应蛋白/多发性骨髓瘤Key words
β2-MG/ CRP/ multiple myeloma分类
医药卫生引用本文复制引用
况小红,童浩,贾霖..血清β2-微球蛋白和C-反应蛋白水平检测在多发性骨髓瘤患者诊断、疗效监测和预后判断中的临床意义[J].四川医学,2011,32(3):347-348,2.
